Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -802,00 | 34,87k | Derivative Exercise and Sale | 58,22 | 28,68k | - |
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 571,00 | 0,00 | Derivative Exercise and Retained Stock | - | 28,68k | 2,03% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 1,62k | 0,00 | Derivative Exercise and Retained Stock | - | 27,35k | 6,28% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -1,69k | 104,45k | Derivative Exercise and Sale | 61,73 | 27,35k | - |
| 2026-04-01 | Mr. David V. ElkinsExec. VP & CFO | -30,00k | 1,85M | Automatic Disposition | 61,60 - 62,05 | 159,54k | -15,83% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 2,25k | 0,00 | Derivative Exercise and Retained Stock | - | 7,92k | 39,65% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -3,64k | 76,67k | Derivative Exercise and Sale | 60,13 | 7,92k | - |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 7,41k | 0,00 | Derivative Exercise and Retained Stock | - | 25,55k | 40,83% |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -18,09k | 466,61k | Derivative Exercise and Sale | 60,13 | 25,55k | - |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | 5,69k | 0,00 | Derivative Exercise and Retained Stock | - | 24,75k | 29,84% |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | -11,81k | 272,69k | Derivative Exercise and Sale | 60,13 | 24,75k | - |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 8,93k | 0,00 | Derivative Exercise and Retained Stock | - | 30,36k | 41,69% |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -16,96k | 395,78k | Derivative Exercise and Sale | 60,13 | 30,36k | - |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 6,70k | 0,00 | Derivative Exercise and Retained Stock | - | 27,91k | 31,56% |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -17,38k | 421,81k | Derivative Exercise and Sale | 60,13 | 27,91k | - |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | 2,40k | 0,00 | Derivative Exercise and Retained Stock | - | 17,36k | 16,00% |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | -3,80k | 81,66k | Derivative Exercise and Sale | 60,13 | 17,36k | - |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | 3,50k | 0,00 | Derivative Exercise and Retained Stock | - | 8,21k | 74,27% |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | -4,69k | 83,64k | Derivative Exercise and Sale | 60,13 | 8,21k | - |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2,07k | 0,00 | Derivative Exercise and Retained Stock | - | 13,13k | 18,66% |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -4,92k | 130,18k | Derivative Exercise and Sale | 60,13 | 13,13k | - |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | 1,90k | 0,00 | Derivative Exercise and Retained Stock | - | 7,32k | 35,03% |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | -4,54k | 119,78k | Derivative Exercise and Sale | 60,13 | 7,32k | - |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | 20,27k | 0,00 | Derivative Exercise and Retained Stock | - | 146,89k | 16,01% |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | -51,27k | 1,28M | Derivative Exercise and Sale | 60,13 | 146,89k | - |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | 21,87k | 0,00 | Derivative Exercise and Retained Stock | - | 189,54k | 13,04% |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | -41,11k | 968,93k | Derivative Exercise and Sale | 60,13 | 189,54k | - |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 16,67k | 10,72% |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | -1,67k | 104,28k | Derivative Exercise and Sale | 62,37 | 16,67k | - |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 21,43k | 8,67% |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -833,00 | 45,86k | Derivative Exercise and Sale | 55,05 | 21,43k | - |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | 6,27k | 0,00 | Derivative Exercise and Retained Stock | - | 15,06k | 71,33% |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | -3,81k | 209,74k | Derivative Exercise and Sale | 55,05 | 15,06k | - |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | 1,18k | 0,00 | Derivative Exercise and Retained Stock | - | 126,62k | 0,94% |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | -1,78k | 57,03k | Derivative Exercise and Sale | 46,07 | 126,62k | - |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 3,62k | 0,00 | Derivative Exercise and Retained Stock | - | 19,72k | 22,46% |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -2,67k | 122,78k | Derivative Exercise and Sale | 46,07 | 19,72k | - |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 18,14k | 20,35% |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -3,21k | 148,02k | Derivative Exercise and Sale | 46,07 | 18,14k | - |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2,23k | 0,00 | Derivative Exercise and Retained Stock | - | 11,07k | 25,18% |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -2,33k | 106,64k | Derivative Exercise and Sale | 45,73 | 11,07k | - |
| 2025-09-02 | Mr. David V. ElkinsExec. VP & CFO | -56,00k | 2,65M | Automatic Disposition | 47,33 | 167,66k | -25,04% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 603,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,67k | 11,90% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -632,00 | 29,82k | Derivative Exercise and Sale | 47,18 | 5,67k | - |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 518,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,84k | 6,22% |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -543,00 | 24,02k | Derivative Exercise and Sale | 44,23 | 8,84k | - |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 360,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,07k | 7,65% |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -378,00 | 16,72k | Derivative Exercise and Sale | 44,23 | 5,07k | - |
| 2025-06-13 | Dr. Christopher S. BoernerCEO & Chairman | -62,72k | 0,00 | Other Disposition | - | 125,44k | -33,33% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
